Ricinin-d3
Ricinine-d3
CAS: 1313734-77-8
Molecular Formula: C8H8N2O2
Ricinin-d3 - Names and Identifiers
Ricinin-d3 - Physico-chemical Properties
| Molecular Formula | C8H8N2O2 |
| Molar Mass | 164.16132 |
| Storage Condition | -20°C |
Ricinin-d3 - Risk and Safety
| Hazard Symbols | Xn - Harmful |
| Risk Codes | R22 - Harmful if swallowed R43 - May cause sensitization by skin contact |
| Safety Description | 36 - Wear suitable protective clothing. |
| WGK Germany | 3 |
Ricinin-d3 - Introduction
Ricinine-d3 is a tricinine molecule labeled with the deuterium isotope (d3). The following is a description of its nature, use, preparation and safety information:
Properties: Ricinine-d3 is an organic compound with a chemical formula of C7H8D3N2O2. It is a colorless crystalline powder. Its mass abundance is above 99%.
Purpose: The Ricinine-d3 is mainly used in scientific research fields, such as toxicology research, drug metabolism research and detection of endogenous substances. As a drug marker, it can be used to track and quantitatively analyze the metabolic pathway and pharmacokinetic parameters of related compounds in vivo.
Preparation method: Ricinine-d3 is mainly prepared by chemical synthesis method. First, acrylic acid labeled with a deuterium isotope is attached to a specific position of the pyridine molecule to form a Ricinine-d3.
Safety information: The Ricinine-d3 has no known obvious hazards during normal use. However, as with all chemicals, it is necessary to comply with relevant laboratory practices and safety measures to avoid direct contact with the skin and inhalation of gases. During use and storage, it should be kept in a dry, cool place and away from flammable substances.
Please note that Ricinine-d3 is a professional compound for scientific research and laboratory applications only and is not suitable for other purposes. Before use, it is recommended to carefully read and understand the relevant chemical safety data sheets (MSDS) and instructions. If necessary, please consult professional advice and guidance.
Properties: Ricinine-d3 is an organic compound with a chemical formula of C7H8D3N2O2. It is a colorless crystalline powder. Its mass abundance is above 99%.
Purpose: The Ricinine-d3 is mainly used in scientific research fields, such as toxicology research, drug metabolism research and detection of endogenous substances. As a drug marker, it can be used to track and quantitatively analyze the metabolic pathway and pharmacokinetic parameters of related compounds in vivo.
Preparation method: Ricinine-d3 is mainly prepared by chemical synthesis method. First, acrylic acid labeled with a deuterium isotope is attached to a specific position of the pyridine molecule to form a Ricinine-d3.
Safety information: The Ricinine-d3 has no known obvious hazards during normal use. However, as with all chemicals, it is necessary to comply with relevant laboratory practices and safety measures to avoid direct contact with the skin and inhalation of gases. During use and storage, it should be kept in a dry, cool place and away from flammable substances.
Please note that Ricinine-d3 is a professional compound for scientific research and laboratory applications only and is not suitable for other purposes. Before use, it is recommended to carefully read and understand the relevant chemical safety data sheets (MSDS) and instructions. If necessary, please consult professional advice and guidance.
Last Update：2024-04-09 21:01:54
Supplier List
Product Name: Ricinine-d3 Visit Supplier Webpage Request for quotation
CAS: 1313734-77-8
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 1313734-77-8
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: Ricinine-d3 Visit Supplier Webpage Request for quotation
CAS: 1313734-77-8
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 1313734-77-8
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History